Liquid biopsy is a new technique that makes it easier to identify and monitor lung cancer without surgery. In India, this ...

UChicago researchers have developed a new blood test that uses RNA modifications to detect early-stage colorectal cancer with ...

While the liquid biopsy technology continues to evolve for lung cancer management, researchers are working toward further ...

NeoGenomics launched the NEO PanTracer™ LBx, a blood-based comprehensive genomic profiling test, expanding the company’s ...

Liquid biopsy technologies are maturing at a rapid pace. They are already being used as a precision medicine tool, helping clinicians match a patient’s cancer to targeted therapies.

A research team has developed a technology that distinguishes lung cancer gene mutations solely by measuring the "stiffness" of exosomes—tiny particles released from cancer cells in the ...

LuminoDx is pleased to announce that they will be presenting the most recent data generated with HepatoTrack, the CLIA ...

Precede Biosciences’ liquid biopsy platform yields insight into the genes and pathways in diseased tissue. Based on Dana-Farber Cancer Institute research, the startup aims to support biopharma ...

Head and neck cancers, often misdiagnosed, face diagnostic delays due to symptom misattribution and misconceptions about ...

Liquid biopsy is a noninvasive diagnostic tool that evaluates biomarkers in the blood and other body fluids. "Noninvasive" means that the sample for the liquid biopsy can be obtained with just a ...